Poly Medicure (Mid Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Poly Medicure Limited |
|||
|
Price: ₹2,509.00 (+1.18%) | ||
| 52 Week Low: ₹1,361.00 52 Week High: ₹3,357.80 |
|||
| Market Capital: 17,404.89 Crore (Midcap) | |||
| Healthcare -> Medical Instruments & Supplies | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Poly Medicure Share Price Target For 2025
- 1.1.1: Poly Medicure Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Poly Medicure Share Price Target For 2026
- 1.2.1: Poly Medicure Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Poly Medicure Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Poly Medicure Brief Company Overview
- 4: Poly Medicure Financial Performance
- 4.0.1: Is Poly Medicure A Good Buy For Long Term?
Poly Medicure, a Mid Cap company in the Medical Instruments & Supplies Industry has delivered 835.0% returns in 5-year showing 23.2% quarterly revenue growth with 18.8% profit margin, making it a potential Multibagger.
To predict the Poly Medicure's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Poly Medicure Share Price Target For 2025
The line chart displays the monthly closing prices of Poly Medicure with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Poly Medicure shares in 2025, see the table below.
Poly Medicure Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 2866.0 (+14.22%) | Price Action: 07 Jan 2025 High |
| 2025 Target 2 | 2837.05 (+13.07%) | Price Action: 10 Dec 2024 Low |
| 2025 Target 1 | 2808.0 (+11.91%) | Price Action: 29 Nov 2024 High |
| Current Price | 2509.00 | Poly Medicure's share price as of 17 Jan 2025 |
| Stop Loss 1 | 2373.4 (-5.41%) | Price Action: 15 Oct 2024 Low |
| Stop Loss 2 | 2342.95 (-6.62%) | Price Action: 27 Sep 2024 High |
| Stop Loss 3 | 2317.45 (-7.64%) | Price Action: 23 Sep 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Poly Medicure is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹2654.07 serves as the nearest technical reference point.
Historical Returns: 3-month: -12.71% | 6-month: +34.22% | 1-year: +72.45%
Poly Medicure Share Price Target For 2026
The line chart displays the monthly closing prices of Poly Medicure with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Poly Medicure shares in 2026, see the table below.
Poly Medicure Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 4211.84 (+67.86%) | Price Action: Chart |
| 2026 Target 2 | 4133.31 (+64.73%) | Price Action: Chart |
| 2026 Target 1 | 4092.39 (+63.1%) | Fibonacci Extension Level 64.90% |
| Current Price | 2509.00 | Poly Medicure's share price as of 17 Jan 2025 |
| Stop Loss 1 | 2145.28 (-14.5%) | Price Action: 23 Aug 2024 Low |
| Stop Loss 2 | 2123.0 (-15.39%) | Price Action: 22 Aug 2024 Low |
| Stop Loss 3 | 2095.54 (-16.48%) | Price Action: 16 Jul 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Poly Medicure is currently trading at 57.5% of its 52-week range (₹1361 - ₹3357.8).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +72.45% | 3-year: +180.13% | 5-year: +834.97%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Poly Medicure Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹2,509.00 | ||
| 2025 | ₹4,400.16 | +75.37% | ₹4,466.16 |
| 2026 | ₹6,981.17 | +58.65% | ₹7,085.89 |
| 2027 | ₹9,567.73 | +37.05% | ₹9,711.25 |
| 2028 | ₹13,114.94 | +37.07% | ₹13,311.66 |
| 2029 | ₹16,334.68 | +24.55% | ₹16,579.70 |
| 2030 | ₹19,785.91 | +21.12% | ₹20,082.70 |
| 2031 | ₹25,967.45 | +31.24% | ₹26,356.96 |
| 2032 | ₹33,118.78 | +27.53% | ₹33,615.56 |
| 2033 | ₹42,797.98 | +29.22% | ₹43,439.95 |
| 2034 | ₹54,852.95 | +28.16% | ₹55,675.74 |
| 2035 | ₹66,277.65 | +20.82% | ₹67,271.81 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Poly Medicure Brief Company Overview
Poly Medicure: A Global Leader in Medical Device Manufacturing Poly Medicure Limited, established in 1995, is a prominent manufacturer and distributor of medical devices in India and internationally. With a diverse product portfolio, Poly Medicure caters to various...
healthcare needs. Poly Medicure's reputation for delivering high-quality and innovative medical devices has earned them recognition in the industry. Their commitment to patient care and safety is evident in their extensive range of products, including infusion devices, nasogastric tubes, endotracheal tubes, dialyzers, blood collection tubes, and more. Poly Medicure's commitment to innovation and customer satisfaction has positioned them as a leading player in the medical device industry, with a presence in over 100 countries.Poly Medicure Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 17,404.89 Crore | Market valuation of Poly Medicure's shares. |
| Revenue (TTM) | 1,375.79 Crore | Total revenue generated by Poly Medicure over the past twelve months. |
| Net Income (TTM) | +258.25 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +21.26% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +18.77% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+23.2% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+16.2% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
11.84 | Company's total debt divided by total shareholder equity. |
| Total Debt | 174.15 Crore | Sum of Poly Medicure's current & long-term financial obligations. |
| Total Cash | 286.39 Crore | Total amount of liquid funds available to Poly Medicure. |
| Beta | 0.34 | Beta is less than 1 indicating that the Poly Medicure's price is less volatile than the market. |
Is Poly Medicure A Good Buy For Long Term?
Poly Medicure, a midcap stock with a market cap of INR 17,404.89 Crore, has shown impressive financial growth in the last 12 months (TTM), with revenue of INR 1,375.79 Crore and a net profit of INR 258.25 Crore. Its strong profitability (net profit margin of 18.77%) and consistent revenue growth (23.2% growth compared to the previous quarter) indicate its stability. With positive past returns (83.45% in the last 12 months), Poly Medicure presents itself as a promising long-term investment opportunity. It is a good buy for investors seeking steady growth and consistent returns.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
